» Articles » PMID: 21151544

Expression of Placental Neurotrophin-3 (NT-3) in Physiological Pregnancy, Preeclampsia and Chorioamnionitis

Overview
Journal Clin Med Pathol
Publisher Libertas Academica
Specialty Pathology
Date 2010 Dec 15
PMID 21151544
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Neurotrophic factors are a group of proteins that act as paracrine and autocrine growth factors. They are involved in the regulation of morphogenesis and development of several tissues. The present study aims to evaluate, for the first time, the expression of Neurotrophin-3 in the human placenta during normal pregnancy and in preeclampsia and chorioamnionitis. Neurotrophin-3 mRNA, assessed by RT-PCR analysis in six term placentas, were observed in all the specimens examined. Neurotrophin-3 protein expression and tissue distribution was evaluated by immunohistochemistry in placenta samples from uncomplicated first trimester (n = 5) and term (n = 5) pregnancies as well as in specimens from preeclampsia (n = 5) and chorioamnionitis (n = 5). In first trimester specimens, strong immunoreactivity was present in villous stromal cells, in the cyto- and syncytiotrophoblast, in decidua cells and in endometrial glands. Third trimester specimens showed prominent immunostaining in cyto- and syncytiotrophoblast cells, in decidua cells and in the amniotic membranes. Villous stromal cells were weakly stained. Similar protein localization was observed in placentas with preeclampsia and chorioamnionitis. In the latter, however, positive villous stromal cells increased in number and in staining intensity when compared with controls and preeclampsia (p < 0.001). The roles of Neurotrophin-3 in pregnancy are presently unknown. A regulatory function on placenta and foetal brain development and maternal inflammatory response may be hypothesized.

Citing Articles

Neurotrophin-4 promotes the specification of trophectoderm lineage after parthenogenetic activation and enhances porcine early embryonic development.

Kim M, Lee J, Cai L, Choi H, Oh D, Jawad A Front Cell Dev Biol. 2023; 11:1194596.

PMID: 37519302 PMC: 10373506. DOI: 10.3389/fcell.2023.1194596.


Detection and Quantification of Neurotrophin-3 (NT-3) and Nerve Growth Factor (NGF) Levels in Early Second Trimester Amniotic Fluid: Investigation into a Possible Correlation with Abnormal Fetal Growth Velocity Patterns.

Machairiotis N, Vrachnis D, Antonakopoulos N, Loukas N, Fotiou A, Pergialiotis V J Clin Med. 2023; 12(12).

PMID: 37373824 PMC: 10299188. DOI: 10.3390/jcm12124131.


Neurotrophic Factor Levels in Preterm Infants: A Systematic Review and Meta-Analysis.

Krey F, Stocchero B, Creutzberg K, Heberle B, Tractenberg S, Xiang L Front Neurol. 2021; 12:643576.

PMID: 33868149 PMC: 8047113. DOI: 10.3389/fneur.2021.643576.

References
1.
Thoenen H . The changing scene of neurotrophic factors. Trends Neurosci. 1991; 14(5):165-70. DOI: 10.1016/0166-2236(91)90097-e. View

2.
Toti P, Ciarmela P, Florio P, Volpi N, Occhini R, Petraglia F . Human placenta and fetal membranes express nerve growth factor mRNA and protein. J Endocrinol Invest. 2006; 29(4):337-41. DOI: 10.1007/BF03344105. View

3.
Ibanez C, Ebendal T, Persson H . Chimeric molecules with multiple neurotrophic activities reveal structural elements determining the specificities of NGF and BDNF. EMBO J. 1991; 10(8):2105-10. PMC: 452896. DOI: 10.1002/j.1460-2075.1991.tb07743.x. View

4.
Bothwell M . Neurotrophin function in skin. J Investig Dermatol Symp Proc. 1997; 2(1):27-30. DOI: 10.1038/jidsymp.1997.7. View

5.
Dechant G . Molecular interactions between neurotrophin receptors. Cell Tissue Res. 2001; 305(2):229-38. DOI: 10.1007/s004410100378. View